Loading...
Loading...
EMBCV| Name | Value |
|---|---|
| Revenues | 286.1M |
| Cost of Revenue | 112.3M |
| Gross Profit | 173.8M |
| Operating Expense | 147.6M |
| Operating I/L | 26.2M |
| Other Income/Expense | -33.2M |
| Interest Income | 0.0M |
| Pretax | -7.0M |
| Income Tax Expense | -21.6M |
| Net Income/Loss | 14.6M |
Embecta Corp. is a medical device company specializing in solutions for diabetes management. The company offers pen needles, syringes, safety devices, and digital applications to aid in diabetes care. Its primary revenue comes from selling these products to wholesalers and distributors in the United States and internationally.
